quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:58:43·22d
SECFiling
Summit Hotel Properties Inc. logo

SEC Form DEFA14A filed by Summit Hotel Properties Inc.

INN· Summit Hotel Properties Inc.
Real Estate
Original source

Companies

  • INN
    Summit Hotel Properties Inc.
    Real Estate

Recent analyst ratings

  • Nov 4UpdateBofA Securities$4.50
  • Apr 30UpdateBofA Securities$5.00
  • Jan 10UpdateWolfe Research-
  • Jan 12UpdateRobert W. Baird$8.00
  • Sep 15UpdateCapitalOne$10.00
  • Jul 14UpdateKeyBanc Capital Markets-

Related

  • PR14h
    SUMMIT HOTEL PROPERTIES DECLARES FIRST QUARTER 2026 DIVIDENDS
  • SEC22d
    SEC Form DEF 14A filed by Summit Hotel Properties Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Summit Hotel Properties Inc.
  • PR29d
    SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2026 EARNINGS RELEASE DATE
  • INSIDER38d
    SVP & Chief Accounting Officer Ruiz Paul returned 37,306 shares to the company and covered exercise/tax liability with 14,326 shares, decreasing direct ownership by 12% to 377,384 units (SEC Form 4)
  • INSIDER38d
    President, CEO & Director Stanner Jonathan P returned 256,477 shares to the company and covered exercise/tax liability with 98,492 shares, decreasing direct ownership by 14% to 2,099,813 units (SEC Form 4)
  • INSIDER38d
    Officer Eng Christopher R. covered exercise/tax liability with 16,089 shares and returned 38,860 shares to the company, decreasing direct ownership by 12% to 414,886 units (SEC Form 4)
  • INSIDER38d
    EVP & Chief Financial Officer Conkling William Higgins covered exercise/tax liability with 29,969 shares and returned 93,264 shares to the company, decreasing direct ownership by 13% to 846,281 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022